MINISTRY OF HEALTH

PHARMACY DEPARTMENT

JUNE 2020 FACILITY TRACER MEDICINES STOCK STATUS REPORT

A Publication of the Ministry of Health

This monthly report on the facility stock status of the 41 tracer items (in different baskets) provides information about the stock situation of health facilities in the country in order to inform the Ministry of Health and all stakeholders to make appropriate logistics decisions that ensure an effective health commodities supply chain.

The report shows the number and percentages of facilities that are appropriately stocked, over stocked or out of stock by level of care and ownership based on Months of Stock (MOS). The MOS highlights the number of months a product will last based on the present consumption rate. It also further indicates facilities that have over 8 months of stock (MOS) broken down by level of care and ownership.

The report shows the availability of the different and overall baskets using two indicators i.e. 1) Average percentage availability of a basket of 41 commodities based on all reporting facilities in the previous cycle Definition : Availability is measured as the number of days for which a specific commodity was in stock at the facility store during the reporting period. 2) Percentage of facilities that had over 95% availability of a basket of commodities in the previous cycle Definition : This indicator measures the % of health facilities that reported having the basket of commodities available during the reporting period.

The contents of the different baskets are listed below: ARV BASKET LOC EMHS BASKET LOC Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/ 600mgHC2 Artemether/Lumefantrine 20/120 mg HC2 AZT/3TC/NVP 300mg/150mg/200mg HC2 Therapeutic milk F75 (75Kcal/100ml) Hospital Atazanavir/ritonavir(ATV/r)300/100mg table* HC3 Oral Liquid Morphine 5ml/ml* HC3 Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg* HC3 Ready to use Therapeutic feeds (RUTF) HC2 TDF/3TC/DTG 300mg/300mg/50mg(TLD)* HC3 Cotrimoxazole 960mg tablet HC2 TLE 300mg/300mg/400mg HC2 Chlorhexidine Digluconate Gel 7.1% HC2 Abacavir/Lamivudine (ABC/3TC) 120mg/60mg (Paediatric) HC3 Bendrofulazide (Aprinox) 5mg HC3 Lopinavir40mg/ritonavir 10mg pellets in capsules* HC3 Artesunate 60mg* HC3 Nifedipine tablets 20mg tablet HC3 LAB BASKET LOC Captopril 25mg tablet HC4 Determine HIV 1 & 2 screening test HC2 Metformin 500mg HC3 Stat -pack HIV Confirmatory rapid tests, tests HC2 Glibenclamide 5mg tablet HC4 SD Bioline test-Tie Breaker HC2 Insulin short-acting HC4 CD4 reagent HC4 Cardiac Aspirin 75/80 mg HC4 Malaria Rapid Diagnostic tests HC2 GeneXepert Catridges* HC3 Blood 450 ml HC4

RMNCAH BASKET LOC TB BASKET LOC Depot medroxy progesterone acetate (DMPA) HC2 (RHZE) blister strip 150/75/400/275 mg HC3 Amoxicillin 250 mg capsule* HC2 RHZ Blister 75mg/50mg/150mg HC3 Sulfadoxine/ Pyrimethamine tablet HC2 ORS Sachets with zinc tablet HC2 Measles-Rubella Vaccine HC2 Misoprostol 200mcg Tablet HC2 Amoxicillin dispersible 250mg tablet HC2 Ceftriaxone 1g Injection HC3 Oxytocin Injection HC3 Note: * New commodity Mama Kit HC2 With the revision of the HMIS tools and change in treatment guidelines a total of eight new commodities were introduced.

KEY FINDINGS 1. The average facility reporting rate per district on HMIS-105 (Stock status) for the month of June 2020 was at 81% and nationally it was at 58% (4456/7659). •A total of twelve districts had 100% reporting for all their facilities while 4 districts had less than 50% of their facilities reporting. Notably, the least reporting districts include; Kayunga, Mukono, Wakiso, and . •Out of the 14 Regional Referral Hospitals; four submitted complete reports and 6 submitted incomplete reports on the 41 tracer commodities. •Arua, , Gulu and Mubende Regional Referral Hospitals did not submit report on the 41 tracer commodities. 2. Overall average availability for the basket of 41 commodities was 81% (n=1692), indicating no percentage change from the month of May 2020 which was 81% (n=1747). a) TB commodities had better availability of 87% (n=665) than other baskets while ARV basket had the least with 73% (n=1157). b) An average of 57% (n=1692) of facilities reported over 95% availability of a basket of commodities, increasing from the month of May 2020 which was 55%. 3. Stocked-outs were reported for; Oral Liquid Morphine 5ml/ml (92%),TLE 300mg/300mg/600mg (89%), RUTF (71%), CD4 reagent (63%) and SD-Bioline test (59%). 4. Overstocked commodities include; ACTs (44%), (RHZE) blister strip 150/75/400/275 mg (45%) and Sulfadoxine/ Pyrimethamine tablet (45%). 5. Expiry of some commodities were reported for RHZ Blister (8%), Determine HIV (5%), (RHZE) blister strip 150/75/400/275 mg (5%), Artemether (4%) and Blood (4%).

ACTION POINTS 1. Pharmacy Department working with regional IPs to ensure that all facilities get adequate stock of legacy regimens from central warehouses. 2. Pharmacy Department will continue monitoring the blood stock levels to inform blood bank decisions for improved blood availability. 3. Pharmacy Department to target their supervisions to the poor performing Regional Referral Hospitals and health facilities 4. Work with the IPs to prioritize and strengthen health facility reporting and quality of data especially for quantity expired. Quality Assurance of the data submitted should be prioritized. 5. Pharmacy Department to support health facilities to report using the new HMIS tools. There is a plan to conduct Regional and Facility Based HMIS Training. This should impove the reporting rate and quality of reports submitted.

June 2020 Facility Stock Status Report 1 of 10 AVAILABILITY INDICATORS

Percentage Average Availability of Basket of commodities Feb'19-Jun'20 Percentage of facilities with over 95% availability of a Basket of commodities 90 Feb'18-Jun'20 90

80 80

70 70

60 60

50 50

40 40

30 30

20 20 Feb- Apr- Aug- Oct- Feb- Apr- Jun- Aug- Oct- Jun-Jul'19 Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Jan-20 Feb-20 Mar-20 Apr-20 May-20 Jun-20 Mar'19 May'19 Sep'19 Nov'19 Mar'19 May'19 Jul'19 Sep'19 Nov'19 EMHS (14 items) 84 81 77 75 76 81 84 83 81 82 80 EMHS (14 items) 48 44 39 38 39 56 59 58 57 57 56 ARV (8 items) 76 76 75 72 72 74 74 73 71 71 73 ARV (8 items) 41 42 42 37 35 43 42 43 39 39 43 LAB (7 items) 87 86 84 84 84 82 83 83 84 84 83 LAB (7 items) 59 57 54 53 54 57 57 59 63 61 61 TB (2 items) 87 88 87 86 85 84 85 87 86 87 87 TB (2 items) 71 72 70 66 67 74 75 77 75 77 76 RMNCAH (10 items) 85 85 82 83 85 78 82 81 81 81 81 RMNCAH (10 items) 45 44 40 42 45 36 41 41 42 41 46

Percentage availability for each item (EMHS basket) Percentage availability for each item (ARV basket) Item n % availty % expiry Item n % availty % expiry 7 Artemether/Lumefantrine 20/120 mg 2010 93% 4.0% Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/1059 79% 600mg 2.4% 8 Therapeutic milk F75 (75Kcal/100ml) 39 54% AZT/3TC/NVP 300mg/150mg/200mg 909 75% 1.3% 11 Oral Liquid Morphine 5ml/ml 283 12% 0.4% Atazanavir/ritonavir(ATV/r)300/100mg table 664 86% 1.1% 12 Ready to use Therapeutic feeds (RUTF)630 36% 0.5% Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg 671 90% 2.4% 14 Cotrimoxazole 960mg tablet 1054 73% 1.0% TDF/3TC/DTG 300mg/300mg/50mg(TLD) 697 94% 1.5% 15 Chlorhexidine Digluconate Gel 7.1% 1019 71% 1.5% TLE 300mg/300mg/600mg 520 16% 0.3% 16 Bendrofulazide (Aprinox) 5mg 644 85% 1.7% Abacavir/Lamivudine (ABC/3TC) 120mg/60mg (Paediatric)650 93% 2.6% 19 Artesunate 60mg 755 86% 0.8% Lopinavir/ritonavir 40mg/10mg pellets in capsules 586 74% 2.9% 20 Nifedipine tablets 20mg tablet 704 82% 1.7% 23 Captopril 25mg tablet 141 69% 0.7% 27 Metformin 500mg 644 83% 1.1% Percentage availability for each item (TB basket) 30 Glibenclamide 5mg tablet 151 83% 2.0% Item n % availty % expiry

32 Insulin short-acting 129 65% 2.8% 4 (RHZE) blister strip 150/75/400/275 mg 639 94% 5.0%

37 Cardiac Aspirin 75/80 mg 147 66% 0.7% 31 RHZ Blister 75mg/50mg/150mg 551 78% 7.8% 38 38 38 147 38 38 38 38 38 38

Percentage availability for each item (RMNCAH basket) Percentage availability for each item (LAB basket) Item n % availty % expiry Item n % availty % expiry Depot medroxy progesterone acetate1499 (DMPA) 79% 1.5% 2 Determine HIV 1 & 2 screening test 1518 83% 5.2% Amoxicillin 250 mg capsule 1966 86% 1.8% 9 Stat -pack HIV Confirmatory rapid tests, tests 1236 80% 1.8% Sulfadoxine/ Pyrimethamine tablet 1706 88% 2.1% 10 SD Bioline test-Tie Breaker 1000 67% 2.1% ORS Sachets with zinc tablet 1892 90% 1.9% 17 CD4 reagent 94 50% 1.7% Measles-Rubella Vaccine 1364 89% 1.6% 33 Malaria Rapid Diagnostic tests 1929 92% 2.8% Misoprostol 200mcg Tablet 1296 85% 2.9% 39 GeneXepert Catridges 90 80% 3.3% Amoxicillin dispersible 250mg tablet 1567 82% 1.4% 40 Blood 450 ml 91 60% 3.9% Ceftriaxone 1g Injection 778 84% 1.2% Oxytocin Injection 682 78% 0.9% Mama Kit 1004 67% 0.8% Note: % expiry - percentage of facilities the reported on expiry

DISTRICT LEAGUE TABLE

Note: The district league table ranks districts based on the percentage of facilities with over 95% availability within the district.

Avg N: Is the average number of facilities that reported on the basket of commodities in the respective districts.

A zero (0) in the table implies that no facility in the respective district had over 95% availability of a given basket of commodities.

100% from the district league table implies that all facilities in the respective district had over 95% availability of a given basket of commodities.

A blank in the leaugue table implies that all facilities in the district submitted incomplete reports for a given basket of commodities.

June 2020 Facility Stock Status Report 2 of 10 District League Table1 (Percentage of Facilities with over 95% availability by District) Facilities Reporting Facilities Reporting Rank District EMHS ARV LAB RMNCAHTB Overall Avg N Total N % reporting Rank District EMHS ARV LAB RMNCAH TB Overall Avg Avg N Total N % reporting 1 91% 83% 91% 87% 100% 91% 24 27 89% 69 57% 33% 20% 44% 100% 51% 24 26 92% 2 100% 100% 100% 50% 88% 9 9 100% 70 40% 50% 78% 27% 60% 51% 35 43 81% 3 100% 80% 91% 67% 100% 87% 33 34 97% 71 56% 29% 50% 19% 100% 51% 17 18 94% 4 92% 100% 86% 67% 80% 85% 21 24 88% 72 58% 17% 67% 77% 33% 50% 13 15 87% 5 81% 91% 80% 67% 100% 84% 28 38 74% 73 100% 0% 50% 27 50 54% 6 85% 91% 78% 81% 83% 84% 46 52 88% 74 42% 14% 64% 46% 83% 50% 18 22 82% 7 Kalaki District 73% 83% 73% 82% 100% 82% 12 12 100% 75 63% 0% 53% 42% 86% 49% 20 21 95% 8 Kampala District 86% 91% 86% 74% 73% 82% 156 1733 9% 76 63% 0% 77% 43% 57% 48% 29 35 83% 9 80% 70% 79% 73% 91% 78% 65 90 72% 77 29% 43% 33% 33% 100% 48% 47 57 82% 10 75% 50% 73% 92% 100% 78% 25 28 89% 78 40% 67% 30% 40% 60% 47% 13 16 81% 11 67% 100% 78% 44% 100% 78% 43 43 100% 79 50% 40% 60% 20% 67% 47% 24 36 67% 12 83% 57% 92% 56% 100% 78% 33 36 92% 80 38% 39% 56% 52% 53% 47% 57 71 80% 13 63% 75% 86% 63% 100% 77% 27 27 100% 81 20% 50% 46% 18% 100% 47% 40 60 67% 14 69% 78% 75% 62% 100% 77% 15 16 94% 82 43% 21% 36% 64% 70% 47% 18 24 75% 15 81% 90% 69% 77% 67% 77% 33 41 80% 83 45% 47% 32% 33% 71% 46% 23 27 85% 16 70% 67% 76% 68% 100% 76% 22 24 92% 84 60% 20% 50% 22% 75% 45% 44 52 85% 17 86% 80% 68% 64% 82% 76% 30 46 65% 85 30% 46% 48% 23% 80% 45% 26 27 96% 18 74% 67% 85% 81% 73% 76% 30 36 83% 86 35% 29% 48% 35% 78% 45% 34 40 85% 19 77% 71% 66% 71% 91% 75% 55 80 69% 87 50% 40% 50% 17% 67% 45% 6 6 100% 20 60% 70% 67% 77% 100% 75% 24 28 86% 88 50% 17% 50% 73% 33% 45% 16 19 84% 21 85% 50% 77% 71% 86% 74% 54 67 81% 89 50% 50% 33% 44% 11 13 85% 22 72% 75% 57% 59% 100% 73% 60 66 91% 90 60% 50% 33% 25% 50% 44% 38 56 68% 23 73% 67% 88% 52% 82% 72% 30 39 77% 91 45% 27% 47% 30% 70% 44% 31 32 97% 24 73% 59% 86% 66% 78% 72% 73 79 92% 92 60% 0% 71% 14% 67% 42% 21 22 95% 25 57% 67% 85% 50% 100% 72% 25 29 86% 93 14% 17% 43% 57% 80% 42% 17 25 68% 26 78% 29% 88% 56% 100% 70% 26 37 70% 94 53% 36% 50% 35% 33% 42% 45 50 90% 27 65% 87% 61% 61% 75% 70% 24 28 86% 95 40% 50% 20% 50% 40% 17 21 81% 28 District 68% 14% 83% 78% 100% 69% 38 40 95% 96 71% 0% 75% 53% 0% 40% 22 24 92% 29 40% 75% 67% 57% 100% 68% 19 20 95% 97 27% 20% 42% 24% 86% 40% 55 59 93% 30 67% 57% 75% 38% 100% 67% 18 19 95% 98 27% 25% 50% 17% 75% 39% 19 20 95% 31 80% 0% 83% 71% 100% 67% 18 20 90% 99 31% 24% 50% 35% 50% 38% 67 119 56% 32 71% 57% 76% 55% 75% 67% 88 94 94% 100 24% 31% 46% 19% 63% 36% 29 41 71% 33 50% 100% 50% 67% 67% 19 33 58% 101 32% 25% 33% 23% 67% 36% 39 41 95% 34 77% 50% 71% 50% 84% 66% 101 134 75% 102 31% 18% 35% 21% 75% 36% 69 78 88% 35 50% 46% 67% 67% 100% 66% 29 89 33% 103 29% 20% 57% 7% 56% 34% 17 19 89% 36 70% 43% 63% 59% 92% 66% 53 63 84% 104 33% 33% 33% 33% 10 13 77% 37 56% 42% 72% 61% 92% 65% 44 47 94% 105 6% 40% 16% 17% 86% 33% 28 29 97% 38 64% 53% 71% 60% 75% 65% 29 41 71% 106 20% 38% 30% 18% 50% 31% 35 53 66% 39 56% 25% 75% 67% 100% 64% 32 51 63% 107 29% 0% 23% 36% 67% 31% 14 16 88% 40 49% 35% 69% 69% 100% 64% 56 120 47% 108 25% 33% 50% 14% 31% 43 63 68% 41 75% 50% 60% 33% 100% 64% 17 17 100% 109 12% 17% 39% 13% 67% 29% 59 88 67% 42 100% 100% 50% 0% 63% 30 32 94% 110 12% 13% 41% 29% 50% 29% 17 23 74% 43 54% 38% 88% 31% 100% 62% 75 108 69% 111 20% 20% 0% 13% 67% 24% 34 58 59% 44 60% 33% 93% 60% 63% 62% 16 23 70% 112 33% 0% 29% 0% 50% 22% 15 17 88% 45 36% 40% 83% 46% 100% 61% 24 39 62% 113 0% 0% 21% 13% 75% 22% 23 23 100% 46 Kassanda District 71% 50% 71% 50% 61% 29 35 83% 114 0% 0% 50% 0% 50% 20% 10 11 91% 47 40% 56% 67% 73% 67% 60% 26 29 90% 115 0% 0% 0% 0% 100% 20% 17 23 74% 48 67% 40% 100% 43% 50% 60% 41 41 100% 116 0% 0% 8% 8% 75% 18% 13 14 93% 49 67% 50% 54% 43% 86% 60% 26 47 55% 117 Luwero District 4% 0% 15% 3% 67% 18% 68 101 67% 50 62% 55% 68% 50% 60% 59% 24 32 75% 118 25% 0% 33% 29% 0% 17% 31 37 84% 51 65% 50% 65% 33% 80% 59% 23 33 70% 119 0% 0% 20% 0% 50% 14% 18 18 100% 52 67% 50% 75% 42% 58% 21 21 100% 120 13% 25% 0% 18% 14% 27 28 96% 53 52% 43% 56% 40% 100% 58% 30 35 86% 121 33% 0% 0% 20% 13% 29 34 85% 54 67% 38% 73% 40% 73% 58% 41 47 87% 122 14% 10% 10% 11% 21 31 68% 55 50% 50% 58% 27% 100% 57% 39 51 76% 123 0% 0% 20% 25% 11% 36 45 80% 56 73% 14% 73% 46% 80% 57% 13 13 100% 124 17% 0% 33% 0% 0% 10% 48 57 84% 57 25% 67% 75% 50% 67% 57% 56 74 76% 125 District 0% 33% 0% 0% 0% 7% 38 54 70% 58 66% 29% 68% 34% 83% 56% 43 50 86% 126 0% 0% 17% 0% 4% 22 32 69% 59 53% 42% 56% 60% 70% 56% 25 33 76% 127 0% 0% 0% 9% 2% 19 24 79% 60 61% 30% 56% 70% 63% 56% 48 56 86% 128 0% 0% 0% 0% 0% 44 58 76% 61 42% 64% 61% 44% 67% 56% 134 617 22% 129 0% 0% 0% 9 11 82% 62 50% 64% 73% 67% 25% 56% 12 14 86% 130 0% 0% 0% 0% 0% 19 29 66% 63 61% 41% 54% 57% 57% 54% 28 42 67% 131 0% 0% 0% 0% 0% 13 15 87% 64 64% 43% 44% 33% 83% 54% 58 68 85% 132 0% 0% 0% 0% 0% 42 46 91% 65 53% 50% 80% 44% 40% 53% 25 26 96% 133 0% 0% 0% 0% 20 22 91% 66 0% 67% 25% 75% 100% 53% 24 35 69% 134 0% 0% 0% 22 29 76% 67 District 61% 41% 68% 46% 46% 52% 51 69 74% 135 19 26 73% 68 Madi-Okollo District 53% 36% 67% 26% 78% 52% 19 19 100%

League table 2: Regional Referral Hospitals Reporting on 41 Tracer Over 95% availability of a basket of commodities commodities Overall Avg Regional Referral Hospital EMHS ARV LAB RMNCAH TB Availty Total N % reporting 1 Moroto RRH 84% 92% 100% 100% 100% 95% 41 100 2 Soroti RRH 58% 93% 67% 91% 100% 82% 41 100 3 Hoima RRH 85% 100% 89% 74% 100% 90% 41 100 4 Mbale RRH 71% 100% 100% 78% 100% 90% 41 100 5 Kabale RRH 65% 95% 83% 70% 100% 83% 40 98 6 Lira RRH 72% 88% 62% 77% 100% 80% 40 98 7 Jinja RRH NR 47% NR 7% NR 27% 18 43 8 Masaka RRH NR 43% NR 7% NR 25% 15 37 9 China Uganda Friendship (Naguru) RRH NR NR 61% NR NR 61% 7 16 10 Mbarara RRH 100% NR NR NR NR 100% 2 5 11 Arua RRH NR NR NR NR NR NR NR NR 12 Fort Portal RRH NR NR NR NR NR NR NR NR 13 Gulu RRH NR NR NR NR NR NR NR NR 14 Mubende RRH NR NR NR NR NR NR NR NR Note: Blank cell - (NR) No Report/ No Data on the 41 Tracer Commodities (Stock status Section)

June 2020 Facility Stock Status Report 3 of 10 EMHS BASKET

Note: No: is the number of facilities Note: Pink shows the stock levels are stocked out or overstocked and need attention Row %: is the percentage of facilities Green: means the stock levels are adequate Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty ($) ACT (Artemether/Lumefantrine 100/200mg) Artemether/Lumefantrine 100/200mg Artemether/Lumefantrine 100/200mg Level of Care Level of Care Level of Care Clinics 7 10 44 60 13 18 9 12 73 100 Clinics 2 2 0 4 Clinics 3 4,644 186 HC 2s 81 8 362 34 139 13 485 46 1067 100 HC 2s 295 6 37 338 HC 2s 38 62,659 2,506 HC 3s 24 4 211 34 103 17 279 45 617 100 HC 3s 167 2 24 193 HC 3s 23 103,238 4,130 HC 4s 4 4 26 28 19 21 43 47 92 100 HC 4s 24 0 3 27 HC 4s 7 36,651 1,466 Gen Hosp 2 4 14 25 12 21 28 50 56 100 Gen Hosp 7 1 8 16 Gen Hosp 2 218,701 8,748 RRH 0 0 3 60 0 0 2 40 5 100 Total 495 11 72 578 Total 73 425,893 17,036 Total 118 6 660 35 286 15 846 44 1910 100

Ownership Comments: ACT (Artemether/Lumenfantrine 100/200mg) Government 91 7 402 29 198 14 710 51 1401 100 •6% and 35% of the facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 11 6 138 70 23 12 25 13 197 100 •44% of the facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 MoS) PNFP 16 5 120 39 65 21 111 36 312 100 •A total of 73 health facilities reported on 425,893 quantity expired of ACT tablets, the majority of the health facilities with Total 118 6 660 35 286 15 846 44 1910 100 expiries being HC2s and HC3s. Value of unit cost $17,036

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty Therapeutic milk F75 (75Kcal/100ml) Therapeutic milk F75 (75Kcal/100ml) Therapeutic milk F75 (75Kcal/100ml) Level of Care Level of Care Level of Care Gen Hosp 18 62 4 14 3 10 4 14 29 100 Gen Hosp 1 1 RRH 0 0 1 14 1 14 5 71 7 100 RRH 2 2 Total 18 50 5 14 4 11 9 25 36 100 Total 3 3

Ownership Comments: Therapeutic milk F75 (75Kcal/100ml) Government 12 48 3 12 3 12 7 28 25 100 •50% and 14% of the facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PNFP 6 55 2 18 1 9 2 18 11 100 •25% of the facilities were overstocked (> 4 MoS). Total 18 50 5 14 4 11 9 25 36 100 •Soroti RRH, Mbale RRH and Anaka Hospital reported over 8 MOS.

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per bottle No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Oral Liquid Morphine 5ml/ml Oral Liquid Morphine 5ml/ml Oral Liquid Morphine 5ml/ml Level of Care Level of Care Level of Care HC 3s 184 98 2 1 2 1 0 0 188 100 HC 4s 1 0 1 HC 4s 1 154 1,408,022 HC 4s 48 98 0 0 0 0 1 2 49 100 Gen Hosp 1 1 2 Gen Hosp 1 10 91,430 Gen Hosp 21 64 7 21 1 3 4 12 33 100 RRH 1 0 1 Total 2 164 1,499,452 RRH 1 17 2 33 2 33 1 17 6 100 Total 3 1 4 Total 254 92 11 4 5 2 6 2 276 100

Ownership Comments: Oral Liquid Morphine 5ml/ml Government 212 94 7 3 3 1 4 2 226 100 •92% and 4% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 1 50 0 0 1 50 0 0 2 100 •Only 6% of the health facilities were overstocked (> 4 MoS). PNFP 41 85 4 8 1 2 2 4 48 100 •A total of 2 health facilities reported on 164 as quantity expired. Value of unit cost Ugx 1,499,452 Total 254 92 11 4 5 2 6 2 276 100

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty Ready to use Therapeutic feeds (RUTF) Ready to use Therapeutic feeds (RUTF) Ready to use Therapeutic feeds Level of Care Level of Care Level of Care Clinics 10 59 4 24 1 6 2 12 17 100 Clinics 1 0 1 HC 2s 178 81 28 13 5 2 8 4 219 100 HC 2s 6 0 6 HC 2s 1 86 HC 3s 170 69 47 19 15 6 14 6 246 100 HC 3s 5 1 6 HC 3s 3 3,150 HC 4s 43 68 14 22 3 5 3 5 63 100 HC 4s 1 0 1 Gen Hosp 1 5 Gen Hosp 16 44 12 33 6 17 2 6 36 100 Gen Hosp 1 0 1 Total 5 3,241 RRH 0 0 4 57 1 14 2 29 7 100 Total 14 1 15 Total 417 71 109 19 31 5 31 5 588 100

Ownership Comments: Ready to use Therapeutic feeds (RUTF) Government 343 72 86 18 21 4 24 5 474 100 •71% and 19% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 16 94 1 6 0 0 0 0 17 100 •5% of the health facilities were overstocked (> 4 MoS). PNFP 58 60 22 23 10 10 7 7 97 100 •A total of 5 health facilities reported on 3,241 Sachets of (RUTF) as quantity expired.. Total 417 71 109 19 31 5 31 5 588 100

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Cotrimoxazole 960mg tablet Cotrimoxazole 960mg tablet Cotrimoxazole 960mg tablet Level of Care Level of Care Level of Care Clinics 7 18 10 26 10 26 11 29 38 100 Clinics 0 1 5 6 Clinics 2 2522 166,452 HC 2s 180 59 59 19 39 13 29 9 307 100 HC 2s 7 4 5 16 HC 2s 4 4,353 287,298 HC 3s 102 22 132 28 106 23 128 27 468 100 HC 3s 59 0 8 67 HC 3s 4 2,055 135,630 HC 4s 19 23 20 24 16 19 29 35 84 100 HC 4s 17 1 2 20 HC 4s 1 2,023 133,518 Gen Hosp 7 13 19 36 14 26 13 25 53 100 Gen Hosp 5 1 3 9 Gen Hosp 2 76 5,016 RRH 5 83 1 17 0 0 0 0 6 100 NRH 1 0 0 1 Total 13 11,029 727,914 NRH 0 0 0 0 0 0 1 100 1 100 Total 89 7 23 119 Total 320 33 241 25 185 19 211 22 957 100 Ownership Comments: Cotrimoxazole 960mg tablet Government 280 42 151 22 95 14 148 22 674 100 •33% and 25% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 13 16 35 44 23 29 9 11 80 100 •22% of the health facilities were overstocked (> 4 MoS). PNFP 27 13 55 27 67 33 54 27 203 100 •A total of 13 health facilities reported on 11,029 tablets as quantity expired. Value of unit cost Ugx 727,914 Total 320 33 241 25 185 19 211 22 957 100

0 <2 Months of 2-4 Stock >4 Total No. of facilities withOwnership over 8 MOS Quantity Expired Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Chlorhexidine Digluconate Gel 7.1% (equivalent to 4% chlorhexidine) Chlorhexidine Digluconate Gel 7.1% Chlorhexidine Digluconate Gel 7.1% Level of Care Level of Care Level of Care Clinics 11 52 7 33 2 10 1 5 21 100 Clinics 2 10 445,000 HC 2s 146 45 69 21 76 23 34 11 325 100 HC 2s 10 1 11 HC 2s 10 2,129 94,740,500 HC 3s 121 36 94 28 72 21 49 15 336 100 HC 3s 14 0 14 HC 3s 6 20 890,000 HC 4s 23 34 19 28 11 16 15 22 68 100 HC 4s 7 0 7 Gen Hosp 1 499 22,205,500 Gen Hosp 16 50 8 25 4 13 4 13 32 100 Gen Hosp 1 1 2 Total 19 2,658 118,281,000 RRH 1 20 1 20 3 60 0 0 5 100 Total 32 0 2 34 Total 318 40 198 25 168 21 103 13 787 100

Ownership Comments: Chlorhexidine Digluconate Gel 7.1% (equivalent to 4% chlorhexidine) Government 234 37 151 24 148 24 97 15 630 100 •40% and 21% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 21 51 15 37 4 10 1 2 41 100 •13% of the health facilities were overstocked (> 4 MoS). PNFP 63 54 32 28 16 14 5 4 116 100 •A total of 19 health facilities reported on 2,658 bottles of Chlorhexidine Digluconate Gel 7.1% as quantity expired. Total 318 40 198 25 168 21 103 13 787 100 Value of unit cost Ugx 118,281,000

June 2020 Facility Stock Status Report 4 of 10 Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty Ugx Bendrofulazide (Aprinox) 5mg Bendrofulazide (Aprinox) 5mg Bendrofulazide (Aprinox) 5mg Level of Care Level of Care Level of Care HC 3s 94 31 83 27 50 16 79 26 306 100 HC 3s 39 1 4 44 HC 3s 7 12133 388,256 HC 4s 15 24 21 34 11 18 15 24 62 100 HC 4s 7 1 1 9 HC 4s 2 3,022 96,704 Gen Hosp 9 20 11 24 10 22 15 33 45 100 Gen Hosp 4 2 2 8 Gen Hosp 2 406 12,992 RRH 1 20 1 20 0 0 3 60 5 100 RRH 3 0 0 3 Total 11 15,561 497,952 Total 119 29 116 28 71 17 112 27 418 100 Total 53 4 7 64

Ownership Comments: Bendrofulazide (Aprinox) 5mg Government 84 28 73 24 51 17 91 30 299 100 •29% and 28% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 2 13 5 33 3 20 5 33 15 100 •27% of the health facilities were overstocked (>4 MoS). PNFP 33 32 38 37 17 16 16 15 104 100 •A total of 11 health facilities reported on 15,561 tablets of Bendrofulazide (5mg) as quantity expired. Total 119 29 116 28 71 17 112 27 418 100 Value of unit cost Ugx 497,952

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty ($) Artesunate 60mg Artesunate 60mg Artesunate 60mg Level of Care Level of Care Level of Care HC 3s 62 12 274 51 94 17 110 20 540 100 HC 3s 42 9 51 HC 3s 4 2,158 4,100 HC 4s 12 13 55 59 11 12 16 17 94 100 HC 4s 6 3 9 Gen Hosp 1 50 95 Gen Hosp 9 16 32 55 11 19 6 10 58 100 Gen Hosp 3 1 4 Total 5 2,208 4,195 RRH 2 40 2 40 0 0 1 20 5 100 Total 51 13 64 Total 85 12 363 52 116 17 133 19 697 100

Ownership Comments: Artesunate 60mg Government 53 10 268 51 93 18 109 21 523 100 •12% and 52% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 4 20 7 35 4 20 5 25 20 100 •19% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 28 18 88 57 19 12 19 12 154 100 •A total 5 health facilities reported on 2,208 tablets of Artesunate (60mg) as quantity expired. Total 85 12 363 52 116 17 133 19 697 100 Value of unit cost $ 4,195

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Nifedipine tablets 20mg Nifedipine tablets 20mg Nifedipine tablets 20mg Level of Care Level of Care Level of Care HC 3s 125 27 198 42 72 15 76 16 471 100 HC 3s 29 0 9 38 HC 3s 8 1,220 28,060 HC 4s 24 28 35 41 13 15 13 15 85 100 HC 4s 4 0 3 7 HC 4s 1 100 2,300 Gen Hosp 7 12 23 40 14 24 14 24 58 100 Gen Hosp 1 1 2 4 Gen Hosp 2 109 2,507 RRH 0 0 2 33 0 0 4 67 6 100 RRH 2 0 0 2 Total 11 1,429 32,867 Total 156 25 258 42 99 16 107 17 620 100 Total 36 1 14 51

Ownership Comments: Nifedipine tablets 20mg tablet Government 135 29 179 39 71 15 75 16 460 100 •25% and 42% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 1 4 11 48 8 35 3 13 23 100 •17% of the health facilities were overstocked (> 4 MoS). Govt owned HC3 facilities formed the larger part of the overstocked (> 8 Mos) PNFP 20 15 68 50 20 15 29 21 137 100 •A total 11 health facilities reported on 1,429 tablets as quantity expired. Total 156 25 258 42 99 16 107 17 620 100 Value of unit cost ugx 32,867

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Captopril 25mg tablet Captopril 25mg tablet Captopril 25mg tablet Level of Care Level of Care Level of Care HC 4s 31 46 20 29 10 15 7 10 68 100 HC 4s 2 1 3 Gen Hosp 15 33 17 38 5 11 8 18 45 100 Gen Hosp 1 2 3 HC 4s 1 2022 188,046 RRH 1 20 4 80 0 0 0 0 5 100 Total 3 3 6 Total 47 40 41 35 15 13 15 13 118 100

Ownership Comments: Captopril 25mg tablet Government 40 47 25 29 11 13 9 11 85 100 •47% and 35% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 3 60 1 20 1 20 5 100 •13% of the health facilities were overstocked (> 4 MoS). PNFP 7 25 13 46 3 11 5 18 28 100 •Kihihi HC IV in Kanungu District reported on 2,022 tablets as quantity expired. The cost value being ugx 188,046 Total 47 40 41 35 15 13 15 13 118 100

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Metformin 500mg Metformin 500mg Metformin 500mg Level of Care Level of Care Level of Care HC 3s 101 27 130 35 76 20 67 18 374 100 HC 3s 27 3 7 37 HC 3s 4 361 10,108 HC 4s 16 18 41 47 16 18 15 17 88 100 HC 4s 5 0 0 5 HC 4s 2 2,121 59,388 Gen Hosp 8 15 25 46 11 20 11 20 55 100 Gen Hosp 5 1 2 8 Gen Hosp 1 9 252 RRH 1 17 1 17 2 33 2 33 6 100 RRH 1 0 0 1 Total 7 2,491 69,748 Total 126 24 197 38 105 20 95 18 523 100 Total 38 4 9 51

Ownership Comments: Metformin 500mg Government 96 25 141 36 79 20 73 19 389 100 •24% and 38% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 2 10 12 60 1 5 5 25 20 100 •18% of the facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 28 25 44 39 25 22 17 15 114 100 •A total 7 health facilities reported on 2,491 tablets of Metformin (500mg) as quantity expired. Total 126 24 197 38 105 20 95 18 523 100 The cost value being ugx 69,748

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Glibenclamide 5mg tablet Glibenclamide 5mg tablet Glibenclamide 5mg tablet Level of Care Level of Care Level of Care HC 4s 21 29 24 33 13 18 15 21 73 100 HC 4s 4 0 3 7 HC 4s 2 2,031 38,589 Gen Hosp 13 25 15 29 7 14 17 33 52 100 Gen Hosp 7 2 2 11 Gen Hosp 1 6 114 RRH 2 33 2 33 1 17 1 17 6 100 Total 11 2 5 18 Total 3 2,037 38,703 Total 36 28 41 31 21 16 33 25 131 100

Ownership Comments: Glibenclamide 5mg tablet Government 25 26 29 31 16 17 25 26 95 100 •28% and 31% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 2 33 2 33 2 33 6 100 •25% of the health facilities were overstocked (> 4 MoS). PNFP 11 37 10 33 3 10 6 20 30 100 •Three health facilities reported on 2,037 tablets of Glibenclamide (5mg) as quantity expired. Total 36 28 41 31 21 16 33 25 131 100 The cost value of expiry being ugx 73,093

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Insulin short-acting Insulin short-acting Insulin short-acting Level of Care Level of Care Level of Care HC 4s 27 44 18 30 11 18 5 8 61 100 HC 4s 4 0 4 HC 4s 1 8 139,432 Gen Hosp 14 31 14 31 10 22 7 16 45 100 Gen Hosp 2 3 5 Gen Hosp 3 68 1,185,172 RRH 1 25 2 50 0 0 1 25 4 100 RRH 1 0 1 Total 4 76 1,324,604 Total 42 38 34 31 21 19 13 12 110 100 Total 7 3 10

Ownership Comments: Insulin short-acting Government 36 43 25 30 14 17 8 10 83 100 •38% and 31% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 1 17 4 67 1 17 0 0 6 100 •12% of the facilities were overstocked (> 4 MoS). PNFP 5 24 5 24 6 29 5 24 21 100 •Four health facilities reported on 76 bottles of Insulin short-acting as quantity expired. Total 42 38 34 31 21 19 13 12 110 100 The cost value of expiry being ugx 1,324,604

June 2020 Facility Stock Status Report 5 of 10 Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Cardiac Aspirin 75/80 mg Cardiac Aspirin 75/80 mg Cardiac Aspirin 75/80 mg Level of Care Level of Care Level of Care HC 4s 35 53 13 20 12 18 6 9 66 100 HC 4s 2 0 2 HC 4s 1 4,100 196,800 Gen Hosp 12 24 16 31 11 22 12 24 51 100 Gen Hosp 0 4 4 RRH 3 60 2 40 0 0 0 0 5 100 Total 2 4 6 Total 50 41 31 25 23 19 18 15 122 100

Ownership Comments: Cardiac Aspirin 75/80 mg Government 44 52 18 21 16 19 7 8 85 100 •41% and 25% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 1 20 2 40 1 20 1 20 5 100 •15% of the health facilities were overstocked (> 4 MoS). PNFP 5 16 11 34 6 19 10 31 32 100 •Obongi HC IV in Obongi District reported on 4,100 tablets of Cardiac Aspirin (75/80 mg) as quantity expired. Total 50 41 31 25 23 19 18 15 122 100 The cost value of expiry being ugx 196,800

ARV BASKET

Note: Stock Status data for new regimes being used under HIV treatment optimization can be from the WAOs/RAAS reports

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/ 600mg TDF/3TC/EFV 300mg/300mg/ 600mg TDF/3TC/EFV 300mg/300mg/ 600mg Level of Care Level of Care Level of Care Clinics 9 29 9 29 7 23 6 19 31 100 Clinics 0 1 1 HC 2s 147 52 60 21 38 14 36 13 281 100 HC 2s 11 3 14 HC 2s 6 15,985 11,589,125 HC 3s 46 9 147 28 124 23 212 40 529 100 HC 3s 84 13 97 HC 3s 17 23,939 17,355,775 HC 4s 4 5 27 30 20 23 38 43 89 100 HC 4s 14 0 14 HC 4s 4 2,775 2,011,875 Gen Hosp 7 12 24 42 12 21 14 25 57 100 Gen Hosp 4 2 6 Gen Hosp 2 53,407 38,720,075 RRH 1 20 1 20 1 20 2 40 5 100 Total 113 0 19 132 Total 29 96,106 69,676,850 NRH 0 0 0 0 1 100 0 0 1 100 Total 214 22 268 27 203 20 308 31 993 100 Ownership Comments: TDF/3TC/EFV 300mg/300mg/ 600mg Government 176 23 184 25 130 17 261 35 751 100 •22% of the health facilities were stocked-out (0 MoS). PFP 15 41 14 38 3 8 5 14 37 100 •31% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 23 11 70 34 70 34 42 21 205 100 •A total of 29 health facilities reported on 96,106 tablets of TDF/3TC/EFV (300mg/300mg/ 600mg) as quantity expired. Total 214 22 268 27 203 20 308 31 993 100 The cost value of expiry being ugx 69,676,850. This item is being phased out, cut off date for a complete phase-out is December 2020.

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) AZT/3TC/NVP 300mg/150mg/200mg AZT/3TC/NVP 300mg/150mg/200mg AZT/3TC/NVP 300mg/150mg/200mg Level of Care Level of Care Level of Care Clinics 11 50 1 5 4 18 6 27 22 100 Clinics 0 0 3 3 HC 2s 3 7182 4,467,204 HC 2s 158 79 21 10 10 5 12 6 201 100 HC 2s 10 0 0 10 HC 3s 8 2,246 1,397,012 HC 3s 48 18 47 17 34 13 143 53 272 100 HC 3s 92 0 5 97 HC 4s 2 2,238 1,392,036 HC 4s 5 11 10 21 8 17 24 51 47 100 HC 4s 16 0 1 17 Gen Hosp 2 3 1,866 Gen Hosp 4 15 7 27 3 12 12 46 26 100 Gen Hosp 2 1 3 6 Total 15 11,669 7,258,118 RRH 0 0 0 0 0 0 4 100 4 100 RRH 2 0 0 2 Total 226 40 86 15 59 10 201 35 572 100 Total 122 1 12 135

Ownership Comments: AZT/3TC/NVP 300mg/150mg/200mg Government 173 39 52 12 44 10 174 39 443 100 •40% and 15% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 17 63 6 22 1 4 3 11 27 100 •35% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 36 35 28 28 14 14 24 24 102 100 •A total of 15 facilities reported on 11,669 tablets as quantity expired. Total 226 40 86 15 59 10 201 35 572 100 The cost value of expiry being ugx 7,258,118. This item is being phased out, cut off date for a complete phase-out is December 2020.

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Atazanavir/ritonavir(ATV/r)300/100mg tablet Atazanavir/ritonavir(ATV/r)300/100mg table Atazanavir/ritonavir(ATV/r) Level of Care Level of Care Level of Care HC 3s 70 18 146 37 79 20 100 25 395 100 HC 3s 44 2 46 HC 3s 3 2,034 3,400,848 HC 4s 6 7 39 47 22 27 16 19 83 100 HC 4s 7 0 7 HC 4s 1 2,022 3,380,784 Gen Hosp 10 21 14 30 14 30 9 19 47 100 Gen Hosp 4 1 5 Gen Hosp 3 172 287,584 RRH 1 14 3 43 1 14 2 29 7 100 RRH 1 0 1 Total 7 4,228 7,069,216 NRH 0 0 0 0 0 0 1 100 1 100 NRH 1 0 1 - Total 87 16 202 38 116 22 128 24 533 100 Total 57 3 60 Ownership Comments: Atazanavir/ritonavir(ATV/r)300/100mg tablet Government 66 16 146 35 87 21 114 28 413 100 •16% and 38% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 1 25 2 50 1 25 4 100 •24% of the health facilities were overstocked (> 4 MoS). PNFP 21 18 55 47 27 23 13 11 116 100 •A total of 7 facilities reported on 4,228 tablets as quantity expired. The cost value of expiry being ugx 7,069,216. Total 87 16 202 38 116 22 128 24 533 100

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg TDF/3TC 300mg/300mg Level of Care Level of Care Level of Care HC 3s 56 14 110 28 68 17 159 41 393 100 HC 3s 76 1 10 87 HC 3s 12 3,570 2,481,150 HC 4s 5 7 23 34 10 15 30 44 68 100 HC 4s 17 0 4 21 HC 4s 1 2,021 1,404,595 Gen Hosp 3 7 13 30 8 19 19 44 43 100 Gen Hosp 2 0 5 7 Gen Hosp 3 82 56,990 RRH 0 0 5 83 0 0 1 17 6 100 RRH 1 0 0 1 Total 16 5,673 3,942,735 NRH 1 100 0 0 0 0 0 0 1 100 Total 96 1 19 116 Total 65 13 151 30 86 17 209 41 511 100 Ownership Comments: Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg Government 51 13 111 28 68 17 169 42 399 100 •13% and 30% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 6 86 0 0 1 14 7 100 •41% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 14 13 34 32 18 17 39 37 105 100 •A total of 16 health facilities reported on 5,673 tablets as quantity expired. The cost value of expiry being ugx 3,942,735 Total 65 13 151 30 86 17 209 41 511 100

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) TDF/3TC/DTG 300mg/300mg/50mg (TLD) TDF/3TC/DTG 300mg/300mg/50mg (TLD) TDF/3TC/DTG 300mg/300mg/50mg Level of Care Level of Care Level of Care HC 3s 26 5 158 32 121 24 197 39 502 100 HC 3s 73 12 85 HC 3s 5 2,539 2,635,482 HC 4s 2 2 22 25 24 28 39 45 87 100 HC 4s 18 0 18 HC 4s 1 2,020 2,096,760 Gen Hosp 4 7 16 30 20 37 14 26 54 100 Gen Hosp 5 3 8 Gen Hosp 4 64 66,432 RRH 0 0 4 80 1 20 0 0 5 100 Total 96 15 111 Total 10 4,623 4,798,674 NRH 0 0 0 0 1 100 0 0 1 100 Total 32 5 200 31 167 26 250 39 649 100 Ownership Comments: TDF/3TC/DTG 300mg/300mg/50mg (TLD) Government 25 5 140 29 117 24 209 43 491 100 •5% and 31% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 3 25 7 58 2 17 12 100 •39% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 7 5 57 39 43 30 39 27 146 100 •A total of 10 health facilities reported on 4,623 tablets as quantity expired. The cost value of expiry being ugx 4,798,674 Total 32 5 200 31 167 26 250 39 649 100

June 2020 Facility Stock Status Report 6 of 10 Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) TLE 300mg/300mg/600mg TLE 300mg/300mg/600mg TLE 300mg/300mg/600mg Level of Care Level of Care Level of Care Clinics 11 92 0 0 0 0 1 8 12 100 HC 3s 2 12 8,700 HC 2s 170 97 1 1 2 1 3 2 176 100 HC 2s 2 0 2 Gen Hosp 1 143 103,675 HC 3s 194 83 14 6 8 3 17 7 233 100 HC 3s 8 2 10 Total 3 155 112,375 HC 4s 43 86 2 4 4 8 1 2 50 100 HC 4s 1 0 1 Gen Hosp 19 83 1 4 3 13 0 0 23 100 Total 11 2 13 RRH 3 100 0 0 0 0 0 0 3 100 Total 440 89 18 4 17 3 22 4 497 100 Ownership Comments: TLE 300mg/300mg/600mg Government 358 89 14 4 14 4 18 5 404 100 •89% and 4% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 16 94 1 6 0 0 0 0 17 100 •Only 4% of the health facilities were overstocked (> 4 MoS). PNFP 66 87 3 4 3 4 4 5 76 100 •A total of 3 health facilities reported on 155 tablets as quantity expired. The cost value of expiry being ugx 112,375 Total 440 89 18 4 17 3 22 4 497 100

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Abacavir/Lamivudine (ABC/3TC) 120mg/60mg (Paediatric) Abacavir/Lamivudine (ABC/3TC) 120mg/60mg (ABC/3TC) 120mg/60mg Level of Care Level of Care Level of Care HC 3s 48 12 99 25 88 23 155 40 390 100 HC 3s 75 1 4 80 HC 3s 13 2,549 1,024,698 HC 4s 3 4 18 25 15 21 35 49 71 100 HC 4s 22 0 2 24 HC 4s 2 233 93,666 Gen Hosp 3 7 9 20 11 24 23 50 46 100 Gen Hosp 13 0 0 13 Gen Hosp 2 834 335,268 RRH 0 0 4 80 0 0 1 20 5 100 RRH 1 0 0 1 Total 17 3,616 1,453,632 Total 54 11 130 25 114 22 214 42 512 100 Total 111 1 6 118

Ownership Comments: Abacavir/Lamivudine (ABC/3TC) 120mg/60mg) Government 38 10 77 20 76 20 192 50 383 100 •11% and 25% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 4 67 1 17 1 17 6 100 •42% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 16 13 49 40 37 30 21 17 123 100 •A total of 17 health facilities reported on 3,616 tablets of Abacavir/Lamivudine (120mg/60mg) as quantity expired. Total 54 11 130 25 114 22 214 42 512 100 The cost value of expiry being ugx 1,453,632

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per capsule No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Lopinavir/ritonavir 40mg/10mg pellets in capsules Lopinavir/ritonavir 40mg/10mg pellets in capsules Lopinavir/ritonavir 40mg/10mg Level of Care Level of Care Level of Care HC 3s 134 47 87 30 32 11 34 12 287 100 HC 3s 15 1 16 HC 3s 16 2,257 1,421,910 HC 4s 16 39 10 24 6 15 9 22 41 100 HC 4s 4 1 5 HC 4s 2 20 12,600 Gen Hosp 11 33 10 30 6 18 6 18 33 100 Gen Hosp 2 2 4 Total 18 2,277 1,434,510 RRH 0 0 3 75 1 25 0 0 4 100 Total 21 4 25 Total 161 44 110 30 45 12 49 13 365 100

Ownership Comments: Lopinavir/ritonavir 40mg/10mg pellets in capsules Government 135 48 82 29 27 10 40 14 284 100 •44% and 30% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 0 0 1 50 1 50 0 0 2 100 •13% of the health facilities were overstocked (> 4 MoS). PNFP 26 33 27 34 17 22 9 11 79 100 •A total of 18 health facilities reported on 2,277 capsules as quantity expired. The cost value of expiry being ugx 1,434,510 Total 161 44 110 30 45 12 49 13 365 100

RMNCAH BASKET

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Depot medroxy progesterone acetate (DMPA) Depot medroxy progesterone acetate (DMPA) Depot medroxy progesterone acetate Level of Care Level of Care Level of Care Clinics 13 32 11 27 7 17 10 24 41 100 Clinics 0 6 1 7 Clinics 2 2,043 2,183,967 HC 2s 169 23 134 18 104 14 328 45 735 100 HC 2s 197 12 18 227 HC 2s 14 12,917 13,808,273 HC 3s 97 23 99 24 85 20 138 33 419 100 HC 3s 75 2 8 85 HC 3s 5 794 848,786 HC 4s 21 32 18 27 12 18 15 23 66 100 HC 4s 7 1 1 9 Gen Hosp 2 276 295,044 Gen Hosp 14 40 6 17 6 17 9 26 35 100 Gen Hosp 2 1 2 5 Total 23 16,030 17,136,070 RRH 3 60 0 0 1 20 1 20 5 100 RRH 1 0 0 1 Total 317 24 268 21 215 17 501 39 1301 100 Total 282 22 30 334

Ownership Comments: Depot medroxy progesterone acetate (DMPA) Government 251 25 181 18 165 16 429 42 1026 100 •24% and 21% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 22 20 40 35 20 18 31 27 113 100 •39% of the health facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 44 27 47 29 30 19 41 25 162 100 •A total of 23 health facilities reported on 16,030 (150 mg/ml) injection as quantity expired. Total 317 24 268 21 215 17 501 39 1301 100 The cost value of expiry being ugx 17,136,070

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per capsule No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Amoxicillin 250 mg capsule Amoxicillin 250 mg capsule Amoxicillin 250 mg capsule Level of Care Level of Care Level of Care Clinics 17 26 39 60 3 5 6 9 65 100 Clinics 1 2 0 3 Clinics 2 2,461 130,433 HC 2s 149 14 484 46 215 21 198 19 1046 100 HC 2s 68 3 16 87 HC 2s 21 145,546 7,713,938 HC 3s 52 8 303 49 145 23 121 20 621 100 HC 3s 46 1 8 55 HC 3s 5 3,415 180,995 HC 4s 10 11 40 43 24 26 20 21 94 100 HC 4s 8 0 0 8 HC 4s 1 2,022 107,166 Gen Hosp 10 16 25 41 13 21 13 21 61 100 Gen Hosp 1 1 4 6 Gen Hosp 2 2,109 111,777 RRH 0 0 4 67 1 17 1 17 6 100 Total 124 7 28 159 Total 31 155,553 8,244,309 Total 238 13 895 47 401 21 359 19 1893 100

Ownership Comments: Amoxicillin 250 mg capsule Government 175 12 622 44 328 23 284 20 1409 100 •13% and 47% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 23 13 122 69 13 7 18 10 176 100 •19% of the health facilities were overstocked (> 4 MoS). PNFP 40 13 151 49 60 20 57 19 308 100 •A total of 31 health facilities reported on 155,553 capsules as quantity expired. The cost value of expiry being ugx 8,244,309 Total 238 13 895 47 401 21 359 19 1893 100

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Sulfadoxine/ Pyrimethamine tablet Sulfadoxine/ Pyrimethamine tablet Sulfadoxine/ Pyrimethamine tablet Level of Care Level of Care Level of Care Clinics 11 22 18 35 10 20 12 24 51 100 Clinics 1 8 1 10 Clinics 2 2,056 207,656 HC 2s 140 20 133 19 84 12 359 50 716 100 HC 2s 259 4 23 286 HC 2s 21 20,881 2,108,981 HC 3s 77 17 99 22 99 22 183 40 458 100 HC 3s 102 2 14 118 HC 3s 8 5,240 529,240 HC 4s 8 11 15 21 15 21 34 47 72 100 HC 4s 23 0 0 23 HC 4s 2 14,142 1,428,342 Gen Hosp 6 15 15 37 8 20 12 29 41 100 Gen Hosp 3 1 3 7 Gen Hosp 2 109 11,009 RRH 0 0 1 25 1 25 2 50 4 100 RRH 1 0 0 1 Total 35 42,428 4,285,228 Total 242 18 281 21 217 16 602 45 1342 100 Total 389 15 41 445

Ownership Comments: Sulfadoxine/ Pyrimethamine tablet Government 160 17 124 13 152 16 508 54 944 100 •18% and 21% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 19 13 71 49 29 20 25 17 144 100 •45% of the health facilities were overstocked (>4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 63 25 86 34 36 14 69 27 254 100 •A total 35 health facilities reported on 42,428 tablets as quantity expired, the majority of facilities wih expiries being HC2s and HC3s. Total 242 18 281 21 217 16 602 45 1342 100 The cost value of expiry being ugx 4,285,228

June 2020 Facility Stock Status Report 7 of 10 Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) ORS Sachets with zinc tablet ORS Sachets with zinc tablet ORS Sachets with zinc tablet Level of Care Level of Care Level of Care Clinics 12 22 19 35 9 16 15 27 55 100 Clinics 1 2 2 5 Clinics 2 2,081 2,996,640 HC 2s 91 9 327 34 208 22 342 35 968 100 HC 2s 159 3 24 186 HC 2s 20 23,689 34,112,160 HC 3s 28 5 220 39 143 25 181 32 572 100 HC 3s 67 1 16 84 HC 3s 6 452 650,880 HC 4s 3 4 31 36 15 17 37 43 86 100 HC 4s 16 1 2 19 HC 4s 2 13,144 18,927,360 Gen Hosp 7 15 9 20 9 20 21 46 46 100 Gen Hosp 10 1 3 14 Gen Hosp 2 37 53,280 RRH 1 14 3 43 0 0 3 43 7 100 RRH 2 0 0 2 Total 32 39,403 56,740,320 Total 142 8 609 35 384 22 599 35 1734 100 Total 255 8 47 310

Ownership Comments: ORS Sachets with zinc tablet Government 81 6 453 34 314 23 496 37 1344 100 •8% and 35% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 21 14 85 57 21 14 21 14 148 100 •32% of the health facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 40 17 71 29 49 20 82 34 242 100 •A total of 32 health facilities reported on 39,403 ORS Sachets with zinc tablet as quantity expired. Total 142 8 609 35 384 22 599 35 1734 100 The cost value of expiry being ugx 56,740,320

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Measles-Rubella Vaccine Measles Measles-Rubella Vaccine Level of Care Level of Care Level of Care Clinics 13 52 6 24 4 16 2 8 25 100 HC 2s 86 2 11 99 Clinics 1 74 1,888,998 HC 2s 163 24 213 31 137 20 165 24 678 100 HC 3s 78 1 14 93 HC 2s 13 24,687 630,185,049 HC 3s 47 10 199 41 90 19 147 30 483 100 HC 4s 14 0 1 15 HC 3s 8 2,279 58,176,033 HC 4s 7 10 27 38 13 18 24 34 71 100 Gen Hosp 5 0 2 7 HC 4s 2 2,030 51,819,810 Gen Hosp 3 7 26 58 6 13 10 22 45 100 Total 183 3 28 214 Total 24 29,070 742,069,890 RRH 0 0 2 40 1 20 2 40 5 100 Total 233 18 473 36 251 19 350 27 1307 100

Ownership Comments: Measles-Rubella Vaccine Government 172 17 360 35 197 19 290 29 1019 100 •18% and 36% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 23 41 18 32 10 18 5 9 56 100 •27% of the health facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 38 16 95 41 44 19 55 24 232 100 •A total of 24 health facilities reported on 29,070 bottles of Measles-Rubella Vaccine (0.5ml/dose) injection as quantity expired. Total 233 18 473 36 251 19 350 27 1307 100 The cost value of expiry being ugx 742,069,890

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Misoprostol 200mg Tablet Misoprostol 200mg Tablet Misoprostol 200mg Tablet Level of Care Level of Care Level of Care Clinics 12 32 12 32 6 16 7 19 37 100 Clinics 0 3 2 5 Clinics 1 2,020 864,560 HC 2s 114 32 71 20 58 16 112 32 355 100 HC 2s 68 4 5 77 HC 2s 17 3,437 1,471,036 HC 3s 61 16 111 29 80 21 130 34 382 100 HC 3s 73 2 8 83 HC 3s 17 5,099 2,182,372 HC 4s 13 17 25 32 16 20 25 32 79 100 HC 4s 11 0 5 16 HC 4s 2 3,021 1,292,988 Gen Hosp 18 33 15 28 9 17 12 22 54 100 Gen Hosp 1 0 5 6 Gen Hosp 3 4,705 2,013,740 RRH 2 33 2 33 1 17 1 17 6 100 RRH 1 0 0 1 Total 40 18,282 7,824,696 Total 220 24 236 26 170 19 287 31 913 100 Total 154 9 25 188

Ownership Comments: Misoprostol 200mg Tablet Government 159 24 155 24 123 19 221 34 658 100 •24% and 26% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 21 26 29 35 16 20 16 20 82 100 •31% of the facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 40 23 52 30 31 18 50 29 173 100 •A total of 40 facilities reported on 18,282 (200mg) tablets as quntity expired, the majority being HC2s and HC3s. Total 220 24 236 26 170 19 287 31 913 100 The cost value of expiry being ugx 7,824,696

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Amoxicillin dispersible 250mg tablet Amoxicillin dispersible 250mg tablet Amoxicillin dispersible 250mg tablet Level of Care Level of Care Level of Care Clinics 13 46 11 39 2 7 2 7 28 100 Clinics 0 0 1 1 HC 2s 14 25,128 1,809,216 HC 2s 104 14 296 39 172 23 193 25 765 100 HC 2s 88 5 6 99 HC 3s 5 2,189 157,608 HC 3s 50 9 210 39 103 19 178 33 541 100 HC 3s 88 1 7 96 HC 4s 1 2,022 145,584 HC 4s 11 14 35 43 13 16 22 27 81 100 HC 4s 12 0 1 13 Gen Hosp 1 9 648 Gen Hosp 9 25 13 36 4 11 10 28 36 100 Gen Hosp 1 0 2 3 Total 21 29,348 2,113,056 RRH 2 40 2 40 0 0 1 20 5 100 RRH 1 0 0 1 Total 189 13 567 39 294 20 406 28 1456 100 Total 190 6 17 213

Ownership Comments: Amoxicillin dispersible 250mg tablet Government 114 10 463 39 251 21 367 31 1195 100 •13% and 39% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 19 24 42 53 11 14 8 10 80 100 •28% of the facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 56 31 62 34 32 18 31 17 181 100 •A total of 21 health facilities reported on 29,348 tablets as quantity expired, the majority being HC2s. Total 189 13 567 39 294 20 406 28 1456 100 The cost value of expiry being ugx 2,113,056

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per injection No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Ceftriaxone 1g Injection Ceftriaxone 1g Injection Ceftriaxone 1g Injection Level of Care Level of Care Level of Care HC 3s 79 14 288 51 96 17 107 19 570 100 HC 3s 37 1 5 43 HC 3s 7 3,116 4,767,480 HC 4s 14 15 62 65 10 11 9 10 95 100 HC 4s 4 0 1 5 Gen Hosp 1 7 10,710 Gen Hosp 8 13 30 47 16 25 10 16 64 100 Gen Hosp 2 0 1 3 Total 8 3,123 4,778,190 RRH 1 14 5 71 0 0 1 14 7 100 RRH 1 0 0 1 Total 102 14 385 52 122 17 127 17 736 100 Total 44 1 7 52

Ownership Comments: Ceftriaxone 1g Injection Government 82 15 272 50 95 17 101 18 550 100 •14% and 52% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 1 4 17 74 2 9 3 13 23 100 •17% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 19 12 96 59 25 15 23 14 163 100 •A total of 8 health facilities reported on 3,123 (1g) injection as quantity expired. Total 102 14 385 52 122 17 127 17 736 100 The cost value of expiry being ugx 4,778,190

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per injection No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Oxytocin Injection Oxytocin Injection Oxytocin Injection Level of Care Level of Care Level of Care HC 3s 127 28 133 29 70 15 131 28 461 100 HC 3s 57 2 13 72 HC 3s 4 2,392 1,219,920 HC 4s 21 27 34 43 11 14 13 17 79 100 HC 4s 8 0 0 8 Gen Hosp 2 132 67,320 Gen Hosp 12 25 17 35 8 17 11 23 48 100 Gen Hosp 2 1 1 4 Total 6 2,524 1,287,240 RRH 1 14 2 29 3 43 1 14 7 100 Total 67 3 14 84 Total 161 27 186 31 92 16 156 26 595 100

Ownership Comments: Oxytocin Injection Government 134 31 117 27 65 15 118 27 434 100 •27% and 31% of the health facilities were stocked-out (0 MoS) and under-stocked (<2 MoS) respectively. PFP 1 5 11 58 1 5 6 32 19 100 •26% of the health facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 26 18 58 41 26 18 32 23 142 100 •A total of 6 health facilities reported on 2,524 bottles of Oxytocin Injection as quantity expired. Total 161 27 186 31 92 16 156 26 595 100 The cost value of expiry being ugx 1,287,240

June 2020 Facility Stock Status Report 8 of 10 Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per kit No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Mama Kit Mama Kit Mama Kit Level of Care Level of Care Level of Care Clinics 12 52 7 30 3 13 1 4 23 100 HC 2s 15 1 1 17 HC 2s 2 61 1,317,356 HC 2s 184 61 55 18 35 12 29 10 303 100 HC 3s 22 0 2 24 HC 3s 7 2,246 48,504,616 HC 3s 129 27 228 47 79 16 51 11 487 100 HC 4s 6 0 1 7 Total 9 2,307 49,821,972 HC 4s 16 19 34 40 17 20 18 21 85 100 Gen Hosp 2 0 0 2 Gen Hosp 17 55 5 16 5 16 4 13 31 100 Total 45 1 4 50 RRH 2 33 2 33 2 33 0 0 6 100 Total 360 39 331 35 141 15 103 11 935 100

Ownership Comments: Mama Kit Government 259 34 289 38 117 16 88 12 753 100 •39% of the health facilities were stocked-out (0 MoS) PFP 21 36 23 40 11 19 3 5 58 100 •11% of the health facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 80 65 19 15 13 11 12 10 124 100 •A total 9 health facilities reported on 2,307 packs of mama kit as quantity expired. The cost value of expiry being ugx 49,821,972 Total 360 39 331 35 141 15 103 11 935 100

LAB BASKET

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per test No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Determine HIV 1 & 2 screening test Determine HIV 1 & 2 screening test Determine HIV 1 & 2 screening test Level of Care Level of Care Level of Care Clinics 7 12 31 53 12 21 8 14 58 100 Clinics 0 2 1 3 Clinics 3 2,363 7,356,019 HC 2s 235 38 185 30 73 12 132 21 625 100 HC 2s 53 7 5 65 HC 2s 32 9,454 29,430,302 HC 3s 68 12 245 42 128 22 144 25 585 100 HC 3s 60 3 8 71 HC 3s 39 64,505 200,804,065 HC 4s 7 8 44 48 17 19 24 26 92 100 HC 4s 8 0 1 9 HC 4s 2 6,323 19,683,499 Gen Hosp 6 10 22 38 16 28 14 24 58 100 Gen Hosp 4 0 3 7 Gen Hosp 3 2,511 7,816,743 RRH 3 43 3 43 1 14 0 0 7 100 Total 125 12 18 155 RRH 1 300 933,900 Total 326 23 530 37 247 17 322 23 1425 100 Total 80 85,456 266,024,528

Ownership Comments: Determine HIV 1 & 2 screening test Government 267 27 329 33 153 15 242 24 991 100 •23% of the health facilities were stocked-out (0 MoS) PFP 15 10 91 58 26 17 25 16 157 100 •23% of the health facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 44 16 110 40 68 25 55 20 277 100 •A total of 80 health facilities reported on 85,456 Determine HIV screening tests as quantity expired. Total 326 23 530 37 247 17 322 23 1425 100 The cost value of expiry being ugx 266,024,528

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per test No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) Stat -pack HIV Confirmatory rapid tests Stat -pack HIV Confirmatory rapid tests Stat -pack HIV Confirmatory rapid tests Level of Care Level of Care Level of Care Clinics 14 40 4 11 10 29 7 20 35 100 Clinics 0 2 1 3 Clinics 2 2,042 7,549,274 HC 2s 181 50 48 13 40 11 91 25 360 100 HC 2s 47 7 12 66 HC 2s 13 4,231 15,642,007 HC 3s 77 21 61 17 63 17 164 45 365 100 HC 3s 75 4 20 99 HC 3s 8 2,225 8,225,825 HC 4s 9 12 22 29 20 27 24 32 75 100 HC 4s 13 0 1 14 HC 4s 1 2,020 7,467,940 Gen Hosp 8 16 11 22 13 27 17 35 49 100 Gen Hosp 4 1 4 9 Gen Hosp 1 71 262,487 RRH 1 20 1 20 1 20 2 40 5 100 Total 139 14 38 191 Total 25 10,589 39,147,533 Total 290 33 147 17 147 17 305 34 889 100

Ownership Comments: Stat -pack HIV Confirmatory rapid tests Government 217 35 102 16 91 15 214 34 624 100 •33% of the health facilities were stocked-out (0 MoS) PFP 20 26 15 20 19 25 22 29 76 100 •34% of the facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 53 28 30 16 37 20 69 37 189 100 •A total of 25 health facilities reported on 10,589 Stat -pack HIV Confirmatory rapid tests as quantity expired. Total 290 33 147 17 147 17 305 34 889 100 The cost value of expiry being ugx 39,147,533

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per test No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) SD Bioline test-Tie Breaker SD Bioline test-Tie Breaker SD Bioline test-Tie Breaker Level of Care Level of Care Level of Care Clinics 14 64 4 18 2 9 2 9 22 100 Clinics 0 1 1 2 Clinics 2 9 28,215 HC 2s 190 75 15 6 17 7 33 13 255 100 HC 2s 12 5 6 23 HC 2s 8 221 692,835 HC 3s 107 47 28 12 31 14 63 28 229 100 HC 3s 32 0 14 46 HC 3s 15 2,395 7,508,325 HC 4s 17 47 7 19 5 14 7 19 36 100 HC 4s 4 0 1 5 Gen Hosp 2 60 188,100 Gen Hosp 11 32 8 24 4 12 11 32 34 100 Gen Hosp 2 1 1 4 Total 27 2,685 8,417,475 RRH 1 25 0 0 2 50 1 25 4 100 Total 50 7 23 80 Total 340 59 62 11 61 11 117 20 580 100

Ownership Comments: SD Bioline test-Tie Breaker Government 262 63 41 10 36 9 75 18 414 100 •59% of the health facilities were stocked-out (0 MoS) PFP 18 40 6 13 11 24 10 22 45 100 •20% of the health facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 60 50 15 12 14 12 32 26 121 100 •A total of 27 health facilities reported on 2,685 SD Bioline test-Tie Breaker as quantity expired. Total 340 59 62 11 61 11 117 20 580 100 The cost value of expiry being ugx 8,417,475

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per tablet No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) CD4 reagent CD4 reagent CD4 reagent Level of Care Level of Care Level of Care HC 4s 36 72 8 16 2 4 4 8 50 100 HC 4s 1 0 1 HC 4s 2 2,071 6,492,585 Gen Hosp 12 46 6 23 3 12 5 19 26 100 Gen Hosp 2 1 3 RRH 2 50 1 25 0 0 1 25 4 100 RRH 1 0 1 Total 50 63 15 19 5 6 10 13 80 100 Total 4 1 5

Ownership Comments: CD4 reagent Government 47 71 8 12 3 5 8 12 66 100 •63% of the health facilities were stocked-out (0 MoS) PNFP 3 21 7 50 2 14 2 14 14 100 •13% of the health facilities were overstocked (> 4 MoS). Total 50 63 15 19 5 6 10 13 80 100 •A total of 2 health facilities reported on 2,071 CD4 reagents as quantity expired. The cost value of expiry being ugx 6,492,585

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per mRDT test No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty ($) Malaria Rapid Diagnostic tests Malaria Rapid Diagnostic tests Malaria Rapid Diagnostic tests Level of Care Level of Care Level of Care Clinics 10 18 26 46 5 9 16 28 57 100 Clinics 2 3 2 7 Clinics 3 4,444 1,280 HC 2s 72 7 347 34 190 19 419 41 1028 100 HC 2s 223 5 20 248 HC 2s 35 1,133,289 326,387 HC 3s 51 9 229 38 97 16 223 37 600 100 HC 3s 116 2 15 133 HC 3s 9 7,738 2,229 HC 4s 9 9 38 40 11 12 38 40 96 100 HC 4s 19 0 1 20 HC 4s 1 50 14 Gen Hosp 10 16 27 44 12 19 13 21 62 100 Gen Hosp 0 3 3 6 Gen Hosp 1 12 3 RRH 1 17 1 17 1 17 3 50 6 100 RRH 2 0 0 2 Total 49 1,145,533 329,914 Total 153 8 668 36 316 17 712 39 1849 100 Total 362 13 41 416

Ownership Comments: Malaria Rapid Diagnostic tests Government 96 7 450 33 225 16 600 44 1371 100 •8% of the health facilities were stocked-out (0 MoS) PFP 20 12 87 54 29 18 25 16 161 100 •39% of the health facilities were overstocked (> 4 MoS). Govt owned HC2 & HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 37 12 131 41 62 20 87 27 317 100 •A total of 49 health facilities reported on 1,145,533 mRDT test kits as quantity expired, the majority with expiries being HC2s and HC3s. Total 153 8 668 36 316 17 712 39 1849 100 The cost value of expiry being $ 329,914.

June 2020 Facility Stock Status Report 9 of 10 Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) GeneXepert Catridges GeneXepert Catridges GeneXepert Catridges Level of Care Level of Care Level of Care HC 3s 0 0 1 25 1 25 2 50 4 100 HC 3s 2 0 2 HC 3s 1 8 310,680 HC 4s 13 32 13 32 10 24 5 12 41 100 HC 4s 1 0 1 HC 4s 1 2,022 78,524,370 Gen Hosp 10 40 4 16 5 20 6 24 25 100 Gen Hosp 3 1 4 Gen Hosp 1 5 194,175 RRH 2 29 4 57 1 14 0 0 7 100 Total 6 1 7 Total 3 2,035 79,029,225 Total 25 33 22 29 17 22 13 17 77 100

Ownership Comments: GeneXepert Catridges Government 20 30 20 30 14 21 12 18 66 100 •33% of the health facilities were stocked-out (0 MoS) PNFP 5 46 2 18 3 27 1 9 11 100 •17% of the health facilities were overstocked (> 4 MoS). Total 25 33 22 29 17 22 13 17 77 100 •A total of 3 health facilities reported on 2,035 GeneXepert Catridges as quantity expired. The cost value of expiry being ugx 79,029,225

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty Blood 450 ml Blood 450 ml Blood 450 ml Level of Care Level of Care Level of Care HC 4s 27 57 18 38 1 2 1 2 47 100 HC 4s 1 2 Gen Hosp 20 61 10 30 2 6 1 3 33 100 Gen Hosp 3 14 RRH 0 0 6 100 0 0 0 0 6 100 RRH 1 5 Total 47 55 34 40 3 4 2 2 86 100 Total 5 21

Ownership Comments: Blood 450 ml Government 34 53 27 42 2 3 1 2 64 100 •55% of the health facilities were stocked-out (0 MoS) PFP 0 0 1 100 0 0 0 0 1 100 •2% of the health facilities reported on overstocked (> 4 MoS) and no facility with over 8 MoS PNFP 13 62 6 29 1 5 1 5 21 100 •A total of 5 health facilities reported on 21 (450ml) of blood as quantity expired. They include; Serere HC IV, Total 47 55 34 40 3 4 2 2 86 100 Moroto Regional Referral Hospitals, Ibanda Hospital, Bwindi Community Hospitals and St. Anthony's Hospital in Tororo.

TB BASKET

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per blister No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) (RHZE) blister strip 150/75/400/275 mg (RHZE) blister strip 150/75/400/275 mg (RHZE) blister strip 150/75/400/275 mg Level of Care Level of Care Level of Care HC 3s 37 13 62 22 62 22 126 44 287 100 HC 3s 61 1 16 78 HC 3s 22 9,364 17,829 HC 4s 2 3 14 23 12 20 32 53 60 100 HC 4s 17 0 2 19 HC 4s 6 4,500 8,568 Gen Hosp 4 11 9 24 10 27 14 38 37 100 Gen Hosp 6 1 3 10 Gen Hosp 4 9,443 17,979 RRH 0 0 2 40 1 20 2 40 5 100 RRH 1 0 0 1 Total 32 23,307 44,377 Total 43 11 87 22 85 22 174 45 389 100 Total 85 2 21 108

Ownership Comments: (RHZE) blister strip 150/75/400/275 mg Government 32 11 66 22 69 23 132 44 299 100 •11% of the health facilities were stocked-out (0 MoS) PFP 1 20 1 20 0 0 3 60 5 100 •45% of the facilities were overstocked (> 4 MoS). Govt owned HC3s formed the larger part of the overstocked (> 8 Mos) PNFP 10 12 20 24 16 19 39 46 85 100 •A total of 32 health facilities reported on 23,307 blister strips as quantity expired. The cost value of expiry being $ 44,377. Total 43 11 87 22 85 22 174 45 389 100

Months of Stock No. of facilities with over 8 MOS Quantity Expired 0 <2 2-4 >4 Total Ownership Unit cost per blister No. Row % No. Row % No. Row % No. Row % No. Row % Govt PFP PNFP Total No. Qty (ugx) RHZ Blister 75mg/50mg/150mg RHZ Blister 75mg/50mg/150mg RHZ Blister 75mg/50mg/150mg

c Level of Care Level of Care Level of Care HC 3s 95 47 40 20 22 11 45 22 202 100 HC 3s 22 7 29 HC 3s 40 8,977 11,311 HC 4s 18 43 8 19 5 12 11 26 42 100 HC 4s 4 2 6 HC 4s 4 3,270 4,120 Gen Hosp 12 55 3 14 3 14 4 18 22 100 Gen Hosp 2 1 3 Gen Hosp 5 190 239 RRH 0 0 0 0 1 25 3 75 4 100 RRH 2 0 2 Total 49 12,437 15,671 Total 125 46 51 19 31 12 63 23 270 100 Total 30 10 40

Ownership Comments: RHZ Blister 75mg/50mg/150mg Government 97 46 37 18 27 13 50 24 211 100 •46% of the health facilities were stocked-out (0 MoS) PFP 1 50 0 0 1 50 0 0 2 100 •23% of the health facilities were overstocked (> 4 MoS). And there were no facilities with over 8 MoS PNFP 27 47 14 25 3 5 13 23 57 100 • A total of 49 health facilities reported on 12,437 Blisters as quantity expired. Total 125 46 51 19 31 12 63 23 270 100 The cost value of expiry being ugx 15,671

June 2020 Facility Stock Status Report 10 of 10